- Home
- ACIU vs VABK Comparison
ACIU vs VABK Comparison
Compare ACIU & VABK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- VABK
- Stock Information
- Founded
- ACIU 2003
- VABK 1998
- Country
- ACIU Switzerland
- VABK United States
- Employees
- ACIU N/A
- VABK N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- VABK Major Banks
- Sector
- ACIU Health Care
- VABK Finance
- Exchange
- ACIU Nasdaq
- VABK Nasdaq
- Market Cap
- ACIU 213.3M
- VABK 201.8M
- IPO Year
- ACIU 2016
- VABK N/A
- Fundamental
- Price
- ACIU $2.14
- VABK $36.88
- Analyst Decision
- ACIU Strong Buy
- VABK
- Analyst Count
- ACIU 1
- VABK 0
- Target Price
- ACIU $12.00
- VABK N/A
- AVG Volume (30 Days)
- ACIU 162.6K
- VABK 5.5K
- Earning Date
- ACIU 08-05-2025
- VABK 07-24-2025
- Dividend Yield
- ACIU N/A
- VABK 3.93%
- EPS Growth
- ACIU N/A
- VABK 14.13
- EPS
- ACIU N/A
- VABK 3.31
- Revenue
- ACIU $36,362,036.00
- VABK $56,012,000.00
- Revenue This Year
- ACIU N/A
- VABK N/A
- Revenue Next Year
- ACIU $533.21
- VABK N/A
- P/E Ratio
- ACIU N/A
- VABK $11.07
- Revenue Growth
- ACIU 86.71
- VABK 8.12
- 52 Week Low
- ACIU $1.43
- VABK $33.53
- 52 Week High
- ACIU $3.98
- VABK $44.00
- Technical
- Relative Strength Index (RSI)
- ACIU 49.10
- VABK 46.32
- Support Level
- ACIU $2.05
- VABK $36.60
- Resistance Level
- ACIU $2.50
- VABK $37.29
- Average True Range (ATR)
- ACIU 0.20
- VABK 0.54
- MACD
- ACIU -0.03
- VABK -0.10
- Stochastic Oscillator
- ACIU 20.00
- VABK 15.14
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About VABK Virginia National Bankshares Corporation
Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.